1. Qi, Bin, Newcomer, Robert G, Sang, Qing-Xiang Amy. . ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. In Current pharmaceutical design, 15, 2336-48. doi:. https://pubmed.ncbi.nlm.nih.gov/19601835/
2. Xu, Shu, Huang, Shengfu, Li, Daiqiang, Yuan, Yuan, Yang, Zhulin. 2020. Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance. In Biomarkers in medicine, 14, 1573-1584. doi:10.2217/bmm-2020-0321. https://pubmed.ncbi.nlm.nih.gov/32960074/
3. Kang, Tze Zhen Evangeline, Zhu, Lina, Yang, Du, Li, Qing, Chan, Kui Ming. 2021. The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer. In The Journal of biological chemistry, 296, 100374. doi:10.1016/j.jbc.2021.100374. https://pubmed.ncbi.nlm.nih.gov/33548228/
4. Li, Huiling, House, John, Nichols, Cody, Zeldin, Darryl, London, Stephanie. 2024. Adam19 Deficiency Impacts Pulmonary Function: Human GWAS Follow-up in Mouse. In Research square, , . doi:10.21203/rs.3.rs-4207678/v1. https://pubmed.ncbi.nlm.nih.gov/38659817/
5. Wang, Y, Lian, Y-M, Ge, C-Y. . MiR-145 changes sensitivity of non-small cell lung cancer to gefitinib through targeting ADAM19. In European review for medical and pharmacological sciences, 23, 5831-5839. doi:10.26355/eurrev_201907_18323. https://pubmed.ncbi.nlm.nih.gov/31298334/
6. Li, Huiling, House, John S, Nichols, Cody E, Zeldin, Darryl C, London, Stephanie J. 2024. Adam19 Deficiency Impacts Pulmonary Function: Human GWAS Follow-up in a Mouse Knockout Model. In Lung, 202, 659-672. doi:10.1007/s00408-024-00738-7. https://pubmed.ncbi.nlm.nih.gov/39153120/
7. Wang, Jiasheng, Guo, Peng, Wu, Dongmei, Hu, Jiajie, Ouyang, Hongwei. 2025. Rejuvenating Hyaline Cartilage with Senescence-Targeting Si-ADAM19 Delivery for Osteoarthritis Therapy. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), , e2414419. doi:10.1002/advs.202414419. https://pubmed.ncbi.nlm.nih.gov/39927476/
智鼠故事 
